Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6NJK
|
||||
| Drug Name |
(5,11-Difluoro-2,3,3a,8-tetrahydro-1-oxa-12b-aza-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine
|
||||
| Synonyms |
CHEMBL314107
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H20F2N2O
|
||||
| Canonical SMILES |
CN(C)CC1CC2N(O1)c3cc(F)ccc3Cc4ccc(F)cc24
|
||||
| InChI |
InChI=1S/C19H20F2N2O/c1-22(2)11-16-10-19-17-8-14(20)5-3-12(17)7-13-4-6-15(21)9-18(13)23(19)24-16/h3-6,8-9,16,19H,7,10-11H2,1-2H3
|
||||
| InChIKey |
GEDGEGJCGBTAON-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.